Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

Recruiting
  • Melanoma
  • Tucson, Arizona
  • +112 more
Jul 26, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Sarcoma, Melanoma, Lung Cancer Trial in United States (PRT1419)

Recruiting
  • Sarcoma
  • +6 more
  • Denver, Colorado
  • +6 more
May 26, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in

Recruiting
  • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
  • +12 more
  • Palo Alto, California
  • +9 more
Mar 24, 2022

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Melanoma Trial in United States (MGA271)

Terminated
  • Melanoma
  • MGA271
  • Los Angeles, California
  • +6 more
Feb 4, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Human Bio-specimens From Melanoma Patients and Clinical Testing

Recruiting
  • Melanoma
  • Tissue and blood collection
  • Nashville, Tennessee
    Vanderbitl-Ingram Cancer Center
Jan 11, 2022

Part 1, MELANOMA, SCCHN Trial in Worldwide (PF-06801591)

Completed
Has Results
  • Part 1
  • +8 more
  • Los Angeles, California
  • +66 more
Oct 29, 2021

Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

Completed
  • Cancer
  • +4 more
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Melanoma Trial in United States (Ipilimumab, Nivolumab)

Completed
Has Results
  • Melanoma
  • Duarte, California
  • +35 more
Sep 8, 2021

Melanoma Trial in Worldwide (nivolumab, ipilimumab)

Completed
Has Results
  • Melanoma
  • nivolumab
  • ipilimumab
  • Tucson, Arizona
  • +123 more
Aug 24, 2021

Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma (ccRCC)
  • +2 more
  • Scottsdale, Arizona
  • +16 more
Aug 16, 2021

Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Melanoma
  • Los Angeles, California
  • +31 more
Jun 11, 2021

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

Completed
  • Advanced Malignancy
  • +6 more
  • AMG 232
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 24, 2021

Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

Terminated
Has Results
  • Melanoma
  • GSK 2132231A
  • Placebo
  • Birmingham, Alabama
  • +256 more
Feb 5, 2021

Melanoma Trial in Worldwide (Dabrafenib, Vemurafenib, Trametinib)

Completed
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +204 more
Feb 8, 2021

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Completed
Has Results
  • Melanoma
  • Scottsdale, Arizona
  • +120 more
Feb 8, 2021

Breast Cancer, NSCLC, Melanoma Trial in Worldwide (Abemaciclib)

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Duarte, California
  • +43 more
Dec 17, 2020